April 29 (Reuters) - The U.S. Food and Drug Administration's website showed on Monday one dose of Novo Nordisk's (NOVOb.CO), opens new tab weight-loss drug Wegovy as available after being in short ...

The overhaul comes after the foundation ousted former chief executive Lars Fruergaard Jørgensen in May, blaming him for an ...

Novo Nordisk's board changes stem from disagreements with the Novo Nordisk Foundation over board composition and strategic ...

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -A boardroom shake-up at Novo Nordisk has handed ...

Novo Nordisk will hold an Extraordinary General Meeting to elect new board members due to a disagreement with the Foundation over board composition. Key board members, including Chair Helge Lund, will ...

Wegovy's list price is $1,349. Novo Nordisk previously announced the discount prescription drug website GoodRx would sell prescribed Ozempic and Wegovy for $499 per month. Consumers also can purchase ...

Further to company announcement no. 28 issued today, an Extraordinary General Meeting of Novo Nordisk A/S is called to elect ...

Novo Nordisk has topped Pfizer’s offer for Metsera with a bid of up to US$9 billion, seeking to secure Metsera’s obesity-drug ...

Novo Nordisk is under fire over a Spanish obesity awareness campaign. After the campaign stirred up controversy, the Spanish ministry of health wrote to the drugmaker about a possible violation of ...

FILE PHOTO: Injection pens and boxes of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo (Reuters) -The U.S. Food and Drug Administration's website showed on Monday ...